ReviewCurrent allergy and asthma reports2026
Obesity-Related Asthma: Structure and Inflammation.
Review in Current allergy and asthma reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewAsthma and obesity are affecting children and teenagers at higher rates than previous generations. Epidemiological data link obesity during childhood with the subsequent development of asthma. In this review we describe developmental and inflammatory factors that contribute to asthma severity in children with obesity. RECENT
findingsAsthma driven by obesity is likely due to both structural and inflammatory changes. Excess weight places mechanical stress on the airway thereby reducing lung volumes. In addition, obesity is linked to chronic inflammation. Adipose tissue releases pro-inflammatory cytokines (IL-6 and TNF-α) which drives the airway towards hyperresponsiveness. This "obesity-related asthma" phenotype does not respond well to corticosteroids making these patients difficult to treat. In children and teenagers, treatment options are limited to currently approved asthma medications; however, improvement in asthma control has been observed in adults utilizing metformin and GLP-1 agonists. Children with obesity are more likely to develop asthma. Their asthma symptoms tend to be more frequent and harder to control. With the rate of obesity on the rise, it is paramount to identify the mechanisms underlying systemic inflammation in those with elevated BMIs. This will allow us to find better treatment options for "obesity-related asthma."
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.